000			01966 a2200481 4500
005			20250513195335.0
264		0	_c19991208
008			199912s 0 0 eng d
022			_a0022-202X
024	7		_a10.1046/j.1523-1747.1999.00749.x _2doi
040			_aNLM _beng _cNLM
100	1		_aAustin, L M
245	0	0	_aThe majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. _h[electronic resource]
260			_bThe Journal of investigative dermatology _cNov 1999
300			_a752-9 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aCD4-CD8 Ratio
650	0	4	_aCell Differentiation _xdrug effects
650	0	4	_aCytokines _xbiosynthesis
650	0	4	_aEpidermal Cells
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInterferon-gamma _xbiosynthesis
650	0	4	_aInterleukin-2 _xbiosynthesis
650	0	4	_aIonomycin _xpharmacology
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPsoriasis _xblood
650	0	4	_aT-Lymphocytes _xdrug effects
650	0	4	_aT-Lymphocytes, Cytotoxic _xmetabolism
650	0	4	_aTetradecanoylphorbol Acetate _xpharmacology
650	0	4	_aTh1 Cells _xcytology
650	0	4	_aTumor Necrosis Factor-alpha _xbiosynthesis
700	1		_aOzawa, M
700	1		_aKikuchi, T
700	1		_aWalters, I B
700	1		_aKrueger, J G
773	0		_tThe Journal of investigative dermatology _gvol. 113 _gno. 5 _gp. 752-9
856	4	0	_uhttps://doi.org/10.1046/j.1523-1747.1999.00749.x _zAvailable from publisher's website
999			_c10527993 _d10527993